Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Wallerian Degeneration

1-methyl-4-phenylpyridinium has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antenor-Dorsey, JA; O'Malley, KL	1

Other Studies

1 other study(ies) available for 1-methyl-4-phenylpyridinium and Wallerian Degeneration

Article	Year
WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity. Molecular neurodegeneration, 2012, Feb-08, Volume: 7 Topics: 1-Methyl-4-phenylpyridinium; Animals; Axons; Cells, Cultured; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; NAD; Nerve Tissue Proteins; Neurites; Neuroprotective Agents; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Wallerian Degeneration	2012

Article

Year

WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.

Molecular neurodegeneration, 2012, Feb-08, Volume: 7

Topics: 1-Methyl-4-phenylpyridinium; Animals; Axons; Cells, Cultured; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; NAD; Nerve Tissue Proteins; Neurites; Neuroprotective Agents; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Wallerian Degeneration

2012